Focus Group Sign-up by May 13th
Dear DSTT participants,
We are excited to invite you to give feedback about your experiences with the DSTT thus far. As you may know, the CSTE has contracted with two external evaluators (David Napp and Jane Conklin). They will be conducting virtual focus groups with DSTT teams in early to mid-June. Per the expectations of the DSTT, all teams are required to participate. Each team will be asked to choose a representative to participate in one 90-minute focus group. Please see our email earlier today with additional details and a Doodle poll to sign up. Contact Kacy if you did not receive the email.
To facilitate scheduling, we ask that teams sign up no later than Friday, May 13.
Thanks,
Kacy
Kacy
We would like to clarify that teams should choose one team member to participate in one 90-minute focus group. When that team member signs up on the Doodle poll, they should put the site name first with the representative's name in parentheses: Acme Health Department (Jay Snow). See original email for more details.
I followed the original link to correct the site name/representative's name, but when I resubmit, it does not give me the option to change anything.
Thanks,
Amanda Bakken
Amanda Bakken, MS, MPH
WNV Surveillance Coordinator and Epidemiology Assistant
Division of Disease Control
ajbakken@nd.gov<mailto:ajbakken@nd.gov> ndhealth.gov/disease 701.328-2385
[cid:image001.jpg@01D86083.4408A870]
health.nd.gov * 600 E. Boulevard Ave., Dept. 301 * Bismarck, ND 58505 * Provide Feedback<https://gcc02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fndhealth.qualtrics.com%2Fjfe%2Fform%2FSV_4NiXJlhtszr0fM9&data=04%7C01%7Cajbakken%40nd.gov%7C1f5f4f4561214c29365708d9c3f830d5%7C2dea0464da514a88bae2b3db94bc0c54%7C0%7C0%7C637756292998027252%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000&sdata=o2sxE7vg5VXnAqzEVjxPUEd4qR3wVfB%2Bi4%2FYKUPczuk%3D&reserved=0>
[cid:image002.png@01D86083.4408A870]<https://gcc02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.facebook.com%2Fndhealth%2F&data=04%7C01%7Cajbakken%40nd.gov%7C1f5f4f4561214c29365708d9c3f830d5%7C2dea0464da514a88bae2b3db94bc0c54%7C0%7C0%7C637756292998037211%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000&sdata=LwvrQ50iSOhY%2F2xahtBs%2BokAjF190o8V5kWtM%2BEebjc%3D&reserved=0> [cid:image003.png@01D86083.4408A870] <https://gcc02.safelinks.protection.outlook.com/?url=https%3A%2F%2Ftwitter.com%2FNDDOH%3Flang%3Den&data=04%7C01%7Cajbakken%40nd.gov%7C1f5f4f4561214c29365708d9c3f830d5%7C2dea0464da514a88bae2b3db94bc0c54%7C0%7C0%7C637756292998037211%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000&sdata=yFHVq8fCL51mldERUm%2FyC9ZiqbGFE6xi%2FviboI6jSnM%3D&reserved=0> [cid:image004.png@01D86083.4408A870] <https://gcc02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.youtube.com%2Fchannel%2FUC0KCh7fxTBftoWOg3kwG5RA%3Fview_as%3Dsubscriber&data=04%7C01%7Cajbakken%40nd.gov%7C1f5f4f4561214c29365708d9c3f830d5%7C2dea0464da514a88bae2b3db94bc0c54%7C0%7C0%7C637756292998047179%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000&sdata=nGwlsnrh4W%2BtvR9emzSvNbx%2FlN%2BFN3JKP5Pn2921wNc%3D&reserved=0>
Confidentiality Notice: This e-mail message, including any attachment(s), is for the sole use of the intended recipient(s) and may contain confidential information. Any unauthorized review, use, disclosure or distribution is strictly prohibited. If you are not the intended recipient, please contact the sender, by e-mail, and destroy all copies of the original message.
We've learned that Doodle recently changed their functionality and no longer allows either Doodle poll participants or event organizers to change names once entered.
Thank you for the update. Yes, I'll be the representative.
Thanks!
Amanda Bakken
Amanda Bakken, MS, MPH
WNV Surveillance Coordinator and Epidemiology Assistant
Division of Disease Control
ajbakken@nd.gov<mailto:ajbakken@nd.gov> ndhealth.gov/disease 701.328-2385
[cid:image001.jpg@01D86098.4CF06CB0]
health.nd.gov * 600 E. Boulevard Ave., Dept. 301 * Bismarck, ND 58505 * Provide Feedback<https://gcc02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fndhealth.qualtrics.com%2Fjfe%2Fform%2FSV_4NiXJlhtszr0fM9&data=04%7C01%7Cajbakken%40nd.gov%7C1f5f4f4561214c29365708d9c3f830d5%7C2dea0464da514a88bae2b3db94bc0c54%7C0%7C0%7C637756292998027252%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000&sdata=o2sxE7vg5VXnAqzEVjxPUEd4qR3wVfB%2Bi4%2FYKUPczuk%3D&reserved=0>
[cid:image002.png@01D86098.4CF06CB0]<https://gcc02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.facebook.com%2Fndhealth%2F&data=04%7C01%7Cajbakken%40nd.gov%7C1f5f4f4561214c29365708d9c3f830d5%7C2dea0464da514a88bae2b3db94bc0c54%7C0%7C0%7C637756292998037211%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000&sdata=LwvrQ50iSOhY%2F2xahtBs%2BokAjF190o8V5kWtM%2BEebjc%3D&reserved=0> [cid:image003.png@01D86098.4CF06CB0] <https://gcc02.safelinks.protection.outlook.com/?url=https%3A%2F%2Ftwitter.com%2FNDDOH%3Flang%3Den&data=04%7C01%7Cajbakken%40nd.gov%7C1f5f4f4561214c29365708d9c3f830d5%7C2dea0464da514a88bae2b3db94bc0c54%7C0%7C0%7C637756292998037211%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000&sdata=yFHVq8fCL51mldERUm%2FyC9ZiqbGFE6xi%2FviboI6jSnM%3D&reserved=0> [cid:image004.png@01D86098.4CF06CB0] <https://gcc02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.youtube.com%2Fchannel%2FUC0KCh7fxTBftoWOg3kwG5RA%3Fview_as%3Dsubscriber&data=04%7C01%7Cajbakken%40nd.gov%7C1f5f4f4561214c29365708d9c3f830d5%7C2dea0464da514a88bae2b3db94bc0c54%7C0%7C0%7C637756292998047179%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000&sdata=nGwlsnrh4W%2BtvR9emzSvNbx%2FlN%2BFN3JKP5Pn2921wNc%3D&reserved=0>
Confidentiality Notice: This e-mail message, including any attachment(s), is for the sole use of the intended recipient(s) and may contain confidential information. Any unauthorized review, use, disclosure or distribution is strictly prohibited. If you are not the intended recipient, please contact the sender, by e-mail, and destroy all copies of the original message.